NASDAQ : MDAI
Spectral AI, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 1.57 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 50.53M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 49.24M |
| Enterprise Value | 51.52M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 32.18M |
| Shares Outstanding | 32.18M |
| Shares Change (YoY) | +40.17% |
| Shares Change (QoQ) | +1.02% |
| Owned by Insiders (%) | 13.40% |
| Owned by Institutions (%) | 14.86% |
| Float | 27.87M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.20 |
| Forward PS | 3.97 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 3.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.90 |
| Quick Ratio | 0.82 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.36 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -41.89% |
| Return on Invested Capital (ROIC) | -316.00% |
| Return on Capital Employed (ROCE) | 2,743.42% |
| Weighted Average Cost of Capital (WACC) | 10.86% |
| Revenue Per Employee | $236,815 |
| Profits Per Employee | -$155,200 |
| Employee Count | 65 |
| Asset Turnover | 0.87 |
| Inventory Turnover | 13.76 |
Taxes
| Measure | Value |
|---|
| Income Tax | 119,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.21 |
| 52-Week Price Change | -29.82% |
| 50-Day Moving Average | 1.59 |
| 200-Day Moving Average | 1.70 |
| Relative Strength Index (RSI) | 45.60 |
| Average Volume (20 Days) | 121,380 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.16M |
| Short Previous Month | 2.35M |
| Short % of Shares Out | 6.72% |
| Short % of Float | 7.76% |
| Short Ratio (days to cover) | 15.66 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 15.39M |
| Gross Profit | 6.61M |
| Operating Income | -11.88M |
| Pretax Income | -9.97M |
| Net Income | -10.09M |
| EBITDA | -11.76M |
| EBIT | -11.88M |
| Loss Per Share | -$0.33 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 13.98M |
| Total Debt | 16.26M |
| Net Cash | -2.28M |
| Net Cash Per Share | -$0.07 |
| Equity (Book Value) | -12.05M |
| Book Value Per Share | -0.37 |
| Working Capital | -2.08M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -12.88M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 119,000 |
| Net Borrowing | 5.99M |
| Free Cash Flow | -12.88M |
| FCF Per Share | -$0.40 |
Margins
| Measure | Value |
|---|
| Gross Margin | 42.92% |
| Operating Margin | -77.17% |
| Pretax Margin | -64.76% |
| Profit Margin | -65.54% |
| EBITDA Margin | -76.40% |
| EBIT Margin | -77.17% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -40.17% |
| Shareholder Yield | -40.17% |
| Earnings Yield | -21.78% |
| FCF Yield | -26.15% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $5.11 |
| Price Target Difference | 234.18% |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 29.05% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -4.85 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |